Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Nelson

Showing results (271-280 of 310) with videos related to

Pageof 31
Sort By:
Journal of Epidemiology and Community Health|June 5, 2024
Gender-specific aspects of socialisation and risk of cardiovascular disease among community-dwelling older adults: a prospective cohort study using machine learning algorithms and a conventional methodAchamyeleh Birhanu Teshale, Htet Lin Htun, Alice J Owen, et al.
Geroscience|November 28, 2024
Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adultsDaniel Clayton-Chubb, Stuart K Roberts, Ammar Majeed, et al.
JAMA Network Open|July 26, 2023
Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical TrialGeoffrey C Cloud, Jeff D Williamson, Le Thi Phuong Thao, et al.
Scientific Reports|March 7, 2023
Associations of body size with all-cause and cause-specific mortality in healthy older adultsPrudence R Carr, Katherine L Webb, Johannes T Neumann, et al.
Age and Ageing|April 25, 2023
Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trialZhen Zhou, Andrea J Curtis, Alice Owen, et al.
Journal of Hypertension|November 13, 2025
Potassium-enriched salt for patients with hypertension: a Hypertension Australia and National Hypertension Taskforce of Australia Position StatementXiaoyue Xu, Mary-Anne Land, Sharon James, et al.
European Journal of Preventive Cardiology|June 6, 2025
Stratification by CVD risk equations does not inform the use of aspirin for primary prevention in older adultsEnayet K Chowdhury, Michael E Ernst, Mark R Nelson, et al.
The Lancet. Healthy Longevity|February 28, 2022
A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial dataJohannes T Neumann, Le T P Thao, Emily Callander, et al.
Journal of the American Heart Association|November 15, 2024
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older PeopleSophia Zoungas, Chris Moran, Andrea J Curtis, et al.
Pilot and Feasibility Studies|July 31, 2024
Protocol for a feasibility registry-based randomised controlled trial investigating a tailored follow-up service for stroke (A-LISTS)Dominique A Cadilhac, Andrew G Ross, Kathleen L Bagot, et al.
Pageof 31

Showing results (271-280 of 310) with videos related to

Sort By:
Pageof 31
Journal of Epidemiology and Community Health|June 5, 2024
Gender-specific aspects of socialisation and risk of cardiovascular disease among community-dwelling older adults: a prospective cohort study using machine learning algorithms and a conventional methodAchamyeleh Birhanu Teshale, Htet Lin Htun, Alice J Owen, et al.
Geroscience|November 28, 2024
Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adultsDaniel Clayton-Chubb, Stuart K Roberts, Ammar Majeed, et al.
JAMA Network Open|July 26, 2023
Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical TrialGeoffrey C Cloud, Jeff D Williamson, Le Thi Phuong Thao, et al.
Scientific Reports|March 7, 2023
Associations of body size with all-cause and cause-specific mortality in healthy older adultsPrudence R Carr, Katherine L Webb, Johannes T Neumann, et al.
Age and Ageing|April 25, 2023
Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trialZhen Zhou, Andrea J Curtis, Alice Owen, et al.
Journal of Hypertension|November 13, 2025
Potassium-enriched salt for patients with hypertension: a Hypertension Australia and National Hypertension Taskforce of Australia Position StatementXiaoyue Xu, Mary-Anne Land, Sharon James, et al.
European Journal of Preventive Cardiology|June 6, 2025
Stratification by CVD risk equations does not inform the use of aspirin for primary prevention in older adultsEnayet K Chowdhury, Michael E Ernst, Mark R Nelson, et al.
The Lancet. Healthy Longevity|February 28, 2022
A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial dataJohannes T Neumann, Le T P Thao, Emily Callander, et al.
Journal of the American Heart Association|November 15, 2024
Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older PeopleSophia Zoungas, Chris Moran, Andrea J Curtis, et al.
Pilot and Feasibility Studies|July 31, 2024
Protocol for a feasibility registry-based randomised controlled trial investigating a tailored follow-up service for stroke (A-LISTS)Dominique A Cadilhac, Andrew G Ross, Kathleen L Bagot, et al.
Pageof 31